Cardiovascular Health & Prostate Cancer
- DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252-71.
- Bosco C, Bosnyak Z, Malmberg A, Adolfsson J, Keating NL, Van Hemelrijck M. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis. Eur Urol2015;68:386-96.
- Romo ML, McCrillis AM, Brite J, Reales D, Dowd JB, Schooling CM. Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review. Eur J Clin Invest 2015;45:475084.